11-07-2005 Comments (0)
Abbott LaboratoriesActosAvandiaEisaiGlaxoSmithKlineGSKHumulin 70-30Humulin NHumulin RInsulinKetoprofenLansoprazoleNovartisOrudisPioglitazonePrevacidPrevacid NapraPACrosiglitazoneSankyoZonegranZonisamide
Tokyo saw a rally in the week ended July 4, with a five-session winning streak. Factors which caused…
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.